We are live on ! Find out more
Fayez Sarofim & Co

Fayez Sarofim & Co Portfolio holdings

AUM $39.1B
1-Year Est. Return 15.14%
This Fund
S&P 500
This Quarter Est. Return
-0.73%
1 Year Est. Return
+15.14%
3 Year Est. Return
+57.14%
5 Year Est. Return
+86.44%
10 Year Est. Return
+281.86%
AUM
$21B
AUM Growth
-$562M
Cap. Flow
-$305M
Cap. Flow %
-1.45%
Top 10 Hldgs %
43.23%
Holding
256
New
8
Increased
47
Reduced
126
Closed
11

Top Buys

Rank Stock Value
1
UNP icon
Union Pacific
UNP
+$92M
2
GILD icon
Gilead Sciences
GILD
+$86.1M
3
CB icon
Chubb
CB
+$11.5M
4
EOG icon
EOG Resources
EOG
+$8.76M
5
STT icon
State Street
STT
+$7.72M

Top Sells

Rank Stock Value
1
ISRG icon
Intuitive Surgical
ISRG
+$55.5M
2
AAPL icon
Apple
AAPL
+$32.3M
3
GE icon
GE Aerospace
GE
+$32.1M
4
XOM icon
ExxonMobil
XOM
+$31.5M
5
KMI icon
Kinder Morgan
KMI
+$22.7M

Sector Composition

Rank Sector Weight
1 Consumer Staples 27.96%
2 Energy 25.29%
3 Financials 12.53%
4 Healthcare 10.76%
5 Technology 9.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TRV icon
126
Travelers Companies
TRV
$78.4B
$1.68M 0.01%
19,687
-36
-0.2% -$3.03K
TDW icon
127
Tidewater
TDW
$3.65B
$1.63M 0.01%
1,040
-10
-1% -$16.3K
MRSH
128
Marsh
MRSH
$91.4B
$1.63M 0.01%
33,016
– –
AMCX icon
129
AMC Global Media
AMCX
$427M
$1.56M 0.01%
21,378
-312
-1% -$21.8K
NSC icon
130
Norfolk Southern
NSC
$75B
$1.47M 0.01%
15,150
-1,059
-7% -$98.2K
CVC
131
DELISTED
CABLEVISION SYS CP NY GRP CL-A
CVC
$1.46M 0.01%
86,767
– –
CNL
132
DELISTED
CLECO CRP (HOLDING CO)
CNL
$1.45M 0.01%
28,710
-2,800
-9% -$136K
BIIB icon
133
Biogen
BIIB
$30.7B
$1.41M 0.01%
4,600
– –
HAL icon
134
Halliburton
HAL
$26.4B
$1.37M 0.01%
23,285
-600
-3% -$32K
CADE
135
DELISTED
Cadence Bank
CADE
$1.34M 0.01%
53,800
– –
AGN
136
DELISTED
Allergan Inc
AGN
$1.29M 0.01%
10,433
+800
+8% +$97.4K
CCH
137
DELISTED
COCA-COLA HBC AG SPONSORED ADR(SWITZERLAND)
CCH
$1.24M 0.01%
50,000
– –
C icon
138
Citigroup
C
$222B
$1.22M 0.01%
25,546
+350
+1% +$17.4K
MSGS icon
139
Madison Square Garden
MSGS
$9.75B
$1.17M 0.01%
28,832
– –
MJN
140
DELISTED
Mead Johnson Nutrition Company
MJN
$1.06M 0.01%
12,758
+267
+2% +$21.6K
SCHW
141
Charles Schwab
SCHW
$181B
$1.05M 0.01%
38,579
-251
-0.6% -$6.56K
GD icon
142
General Dynamics
GD
$103B
$1.05M 0.01%
9,646
-1,435
-13% -$149K
LOW icon
143
Lowe's Companies
LOW
$118B
$1.05M 0.01%
21,472
-275
-1% -$13.3K
PBR.A icon
144
Petrobras Class A
PBR.A
$109B
$1.05M 0.01%
75,700
– –
BDX icon
145
Becton Dickinson
BDX
$45.6B
$1.02M ﹤0.01%
8,906
-1,420
-14% -$156K
YHOO
146
DELISTED
Yahoo Inc
YHOO
$986K ﹤0.01%
27,455
-1,451
-5% -$55.4K
BAX icon
147
Baxter International
BAX
$13.8B
$957K ﹤0.01%
23,933
-4,234
-15% -$158K
BMY icon
148
Bristol-Myers Squibb
BMY
$132B
$944K ﹤0.01%
18,176
-200
-1% -$10.6K
NEE icon
149
NextEra Energy
NEE
$183B
$938K ﹤0.01%
39,228
-3,136
-7% -$71.1K
YUM icon
150
Yum! Brands
YUM
$43.3B
$926K ﹤0.01%
17,075
+905
+6% +$47.7K
4 5
6
7 8

Similar funds

Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return
Nomura Asset Management
Nomura Asset Management Tokyo, Japan $38.8B AUM 30.94% 1-Year Est. Return
Parallax Volatility Advisers
Parallax Volatility Advisers San Francisco, California $38.6B AUM 45.89% 1-Year Est. Return
Empower Advisory Group
Empower Advisory Group Greenwood Village, Colorado $38.5B AUM 18.4% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Credit Agricole
Credit Agricole Montrouge Cedex, France $38.1B AUM
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return

Fayez Sarofim & Co's Q1 2014 Portfolio in Review

As of Q1 2014, Fayez Sarofim & Co held 256 positions worth $21B, down 2.6% from $21.5B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Fayez Sarofim & Co's Q1 2014 filing shows 8 new, 47 increased, 126 reduced and 11 closed positions. Its largest new stake was Gilead Sciences: 1,098,306 shares worth $78.4M. The largest sale was Intuitive Surgical, an estimated $55.5M.

By sector, the portfolio is most concentrated in Consumer Staples at 28% of assets, down from 29% a quarter earlier, followed by Energy and Financials.

  • Fayez Sarofim & Co's largest Q1 2014 buy was Gilead Sciences: 1,098,306 shares worth $78.4M.
  • Fayez Sarofim & Co added most to Union Pacific in Q1 2014, an estimated $92M increase.
  • Fayez Sarofim & Co's biggest Q1 2014 reduction was Intuitive Surgical, cutting an estimated $55.5M.
  • Fayez Sarofim & Co fully exited State Street SPDR S&P 500 ETF Trust in Q1 2014, selling an estimated $3.03M.
  • Fayez Sarofim & Co's ten largest holdings make up 43% of its $21B portfolio in Q1 2014.
  • Fayez Sarofim & Co opened 8 new positions and closed 11 in Q1 2014.
  • Fayez Sarofim & Co's portfolio value fell 2.6% quarter-over-quarter to $21B.

Based on Fayez Sarofim & Co's 13F filing for Q1 2014, filed 14 May 2014.